Crossmark

Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures

Crossref DOI link: https://doi.org/10.1186/s12885-018-4473-8

Published Online: 2018-05-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mosaad, Eman

Chambers, Karen

Futrega, Kathryn

Clements, Judith

Doran, Michael Robert
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1130013, APP1108043)

Prostate Cancer Foundation of Australia
License Information

Text and Data Mining valid from 2018-05-24
More Information

Article History

Received: 28 November 2017

Accepted: 1 May 2018

First Online: 24 May 2018

Ethics approval and consent to participate

: None of the prostate cancer cell lines used in this study required institutional human ethics approval. Only the collection of bone marrow aspirate donations required human ethics approval. Ethical approval was granted through the Mater Health Services Human Research Ethics Committee and Queensland University of Technology Ethics Committee (number: 1000000938), in accordance with the Australian National Health and Medical Research Council’s Statement on Ethical Conduct in Research Involving Humans. Volunteer bone marrow donors were informed, and provided written consent prior to participating.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.